ConductScience.org, home

Trial · NCT07055945

Investigation of the Effects of Visual-Motor Based Training on Upper Extremity Functions in Individuals With Stroke

NCT07055945, Not applicable, Recruiting, Baskent University

3 sourcestrials-2026-11-12-0.4.0

Download JSON
Cite this record

ConductScience Library. Investigation of the Effects of Visual-Motor Based Training on Upper Extremity Functions in Individuals With Stroke. Trials, record NCT07055945. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07055945

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Investigation of the Effects of Visual-Motor Based Training on Upper Extremity Functions in Individuals With Stroke
NCT number
NCT07055945
Status
Recruiting
Phases
Not applicable
Enrollment
38 participants, estimated
Lead sponsor
Baskent University
Conditions
Stroke
Interventions
Experimental group, Control group
First posted
2025-07-09
Last updated
2025-09-04

Source ClinicalTrials.gov

Registered outcomes7

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryModified Ashworth Scaleeight weeks
Modified Ashworth Scale (MAS) will be used to evaluate the muscle tone of the \*\*shoulder, elbow, wrist, and finger flexors\*\* in post-stroke patients. This scale will be applied both as part of the \*\*initial assessment\*\* for determining eligibility and to evaluate the \*\*effectiveness of the intervention\*\* by comparing pre- and post-treatment scores. MAS grades muscle tone on a 6-point ordinal scale.Each measurement will be performed twice. Data will be entered into the statistical database both as ordinal values (0 to 4) and using a coding system for further analysis. Patients will be evaluated pre- and post-treatment using the MAS.
PrimaryFugl-Meyer Upper Extremity Assessmenteight weeks
The Fugl-Meyer Motor Assessment Scale is a performance-based motor impairment scale developed to evaluate recovery in individuals with stroke. This scale includes subtests that assess upper and lower extremity functions, balance, sensation, and posture. In our study, the upper extremity gross and fine motor functions of patients will be assessed using the Fugl-Meyer Upper Extremity (FM-UE) Assessment Scale. The maximum score that can be obtained in the assessment is 66, with higher scores indicating better motor function. Patients will be evaluated pre- and post-treatment using the Fugl-Meyer Assessment Scale.
PrimaryWolf Motor Function Testeight weeks
The Wolf Motor Function Test (WMFT) is a test developed to evaluate motor skills in patients with moderate to severe upper extremity motor deficits The original version was developed by Wolf and colleagues. In our study, the modified version developed by Morris and colleagues will be used.Data will be collected for 15 activities in two areas: "functional ability" and "performance time". The duration of the test is 30-45 minutes.Each activity will be rated by the physiotherapist using a scale of 0 to 5 based on the functional ability section, where:0 = "The affected hand is not used at all during the activity",5 = "Normal movement".The average score for functional ability will be calculated, and based on this, the patient will receive a score between 0 and 5, with higher scores indicating good functional ability.The performance time will be recorded in seconds.The maximum time given to complete an activity is 120seconds.Patients will be evaluated pre- and post-treatment using the WMFT
PrimaryPurdue Pegboard Testeight weeks
The Purdue Pegboard Test(PPT) is used to assess the motor skills and coordination of the upper extremity. The test consists of a board with two parallel rows of 25 holes, along with pegs, rings, and small pins.In our study, upper extremity motor skills and coordination will be evaluated using the PPT. Scoring: Each pin inserted with the right or left hand earns 1 point, each pair of pins inserted with both hands earns 1 point, and each completed combination (pin, washer, and nut) is worth 4 points. Patients will be evaluated pre- and post-treatment using the PPT.
SecondaryCognitive functions: Stroop Test-Interference Formeight weeks
The Stroop test is a cognitive assessment that evaluates executive functions and measures attention, the inhibition of inappropriate automatic responses, and perception under disruptive influence. The Stroop effect not only measures executive functions but also assesses processing speed, automatic, and parallel processing. The Stroop effect occurs when there is a conflict between the color name written and the color used to write it. When the colors are different, reading the word becomes slower compared to reading words that are written in the same color, and the difference between these two speeds is referred to as the Stroop effect. The Stroop effect not only measures executive functions but also assesses processing speed, automatic, and parallel processing. A longer completion time and a higher error count indicate weak cognitive flexibility. Patients will be evaluated pre- and post-treatment using the Stroop test.
SecondaryPostural Assessment Scale for Stroke Patientseight weeks
The Postural Assessment Scale for Stroke Patients (PASS) is designed to evaluate postural control and balance in detail. The scale assesses balance during tasks such as lying, sitting, standing, or changing positions. Each task is rated from 0 (lowest) to 3 (highest). The total score ranges from 0 to 36. Higher scores on the PASS indicate better postural stability and functional independence, with a maximum score of 36 representing full postural competence. Patients will be evaluated pre- and post-treatment using the PASS.
SecondaryTrunk functions: Body Disorder Scale (BDS)eight weeks
BDS is a tool used to assess motor dysfunctions resulting from stroke and to measure the quality of body movements. The scale consists of 17 parameters and is used to evaluate somatic, motor, and coordination deficits in stroke patients. The scale is divided into three subcategories: static sitting balance, dynamic sitting balance, and coordination. The total score ranges from 0 to 23 points, with higher scores indicating better performance. Patients will be evaluated pre- and post-treatment using the BDS.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests1

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed as
Stroop Color-Word TestSecondary outcome

Source

Release
trials-2026-11-12-0.4.0
Release manifest SHA-256
0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
Registry capture
2026-11-12
Results copy, AACT
2026-03-23
NIH clinical studies file
2026-11-13

Source ClinicalTrials.gov

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07055945

GET https://conductscience.org/api/trials/v1/NCT07055945/registered